{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:12:29Z","timestamp":1773097949171,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10067-020-05193-2","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T05:04:05Z","timestamp":1591592645000},"page":"2043-2047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-2235","authenticated-orcid":false,"given":"Martina","family":"Orlandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-6937","authenticated-orcid":false,"given":"Gemma","family":"Lepri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-2083","authenticated-orcid":false,"given":"Cosimo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Zammarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cometi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bellando-Randone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"5193_CR1","doi-asserted-by":"publisher","first-page":"m408","DOI":"10.1136\/bmj.m408","volume":"368","author":"E Mahase","year":"2020","unstructured":"Mahase E (2020) China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ 368:m408","journal-title":"BMJ"},{"key":"5193_CR2","unstructured":"https:\/\/covid19.who.int\/ (Accessed 28 April 2020)"},{"key":"5193_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1183\/16000617.00002915","volume":"24","author":"S Cappelli","year":"2015","unstructured":"Cappelli S, Bellando Randone S, Camiciottoli G, de Paulis A, Guiducci S, Matucci-Cerinic M (2015) Interstitial lung disease in systemic sclerosis: where do we stand? Eur Respir Rev 24:411\u2013419","journal-title":"Eur Respir Rev"},{"key":"5193_CR4","doi-asserted-by":"crossref","unstructured":"Mihai C, Dobrota R, Schr\u00f6der M, et al (2020) COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD Ann Rheum Dis; annrheumdis-2020-217442","DOI":"10.1136\/annrheumdis-2020-217442"},{"key":"5193_CR5","doi-asserted-by":"crossref","unstructured":"D'Antiga L (2020) Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. March 20","DOI":"10.1002\/lt.25756"},{"key":"5193_CR6","doi-asserted-by":"publisher","first-page":"102442","DOI":"10.1016\/j.jaut.2020.102442","volume":"2","author":"A Ceribelli","year":"2020","unstructured":"Ceribelli A, Motta F, De Santis M et al (2020) Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun Apr 2:102442","journal-title":"J Autoimmun Apr"},{"key":"5193_CR7","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Perlman S (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol (5):39, 529\u2013539","DOI":"10.1007\/s00281-017-0629-x"},{"key":"5193_CR8","unstructured":"Xu M Xh, Li T, Sun W, et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. ChinaXiv; 20200300026"},{"issue":"12","key":"5193_CR9","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.autrev.2019.102403","volume":"18","author":"J Blagojevic","year":"2019","unstructured":"Blagojevic J, Legendre P, Matucci-Cerinic M et al (2019) Is there today a place for corticosteroids in the treatment of scleroderma? Autoimmun Rev 18(12):102403","journal-title":"Autoimmun Rev"},{"key":"5193_CR10","unstructured":"EULAR guidance for patients during Covid-19 outbreak. https:\/\/www.eular.org\/eular_guidance_for_patients_covid19_outbreak.cfm"},{"key":"5193_CR11","unstructured":"ACR guidance for patients during Covid-19 outbreak. https:\/\/www.rheumatology.org\/announcements. (Accessed 28 April 2020)"},{"issue":"6","key":"5193_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jbspin.2016.10.002","volume":"84","author":"C Bruni","year":"2017","unstructured":"Bruni C, Praino E, Guiducci S, Bellando-Randone S, Furst DE, Matucci-Cerinic M (2017) Hydroxychloroquine and joint involvement in systemic sclerosis: preliminary beneficial results from a retrospective case-control series of an EUSTAR center. Joint Bone Spine 84(6):747\u2013748","journal-title":"Joint Bone Spine"},{"issue":"10","key":"5193_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/hiv.12295","volume":"16","author":"A Chauhan","year":"2015","unstructured":"Chauhan A, Tikoo A, AJHM T (2015) The enigma of the clandestine association between chloroquine and HIV-1 infection. HIV Med 16(10):585\u2013590","journal-title":"HIV Med"},{"issue":"8","key":"5193_CR14","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1128\/AAC.01509-08","volume":"53","author":"E Keyaerts","year":"2009","unstructured":"Keyaerts E, Li S, Vijgen L, Rysman E, Verbeeck J, van Ranst M, Maes P (2009) Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 53(8):3416\u20133421","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5193_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2020","unstructured":"Vincent MJ, Bergeron E, Benjannet S et al (2020) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2(1):69","journal-title":"Virol J"},{"issue":"3","key":"5193_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271","journal-title":"Cell Res"},{"issue":"1","key":"5193_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X (2020) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14(1):72","journal-title":"Biosci Trends"},{"key":"5193_CR18","unstructured":"Chen J, Liu D, Liu L et al (2020) A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). Journal of ZheJiang University 49(1)"},{"issue":"20","key":"5193_CR19","first-page":"30390","volume":"S0883\u20139441","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Ingoglia G, Ippolito M et al (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care S0883\u20139441(20):30390\u201330397","journal-title":"J Crit Care"},{"key":"5193_CR20","doi-asserted-by":"publisher","first-page":"m1432","DOI":"10.1136\/bmj.m1432","volume":"369","author":"RE Ferner","year":"2020","unstructured":"Ferner RE, Aronson JK (2020) Chloroquine and hydroxychloroquine in covid-19. BMJ 369:m1432","journal-title":"BMJ"},{"key":"5193_CR21","doi-asserted-by":"crossref","unstructured":"Gbinigie K, Frie K (2020) Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review. BJGP Open","DOI":"10.3399\/bjgpopen20X101069"},{"key":"5193_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team (2020) Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 69:382\u2013386","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5193_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418\u2013423","journal-title":"J Med Virol"},{"key":"5193_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112\u2013116","journal-title":"Nature"},{"key":"5193_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray M, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research Group (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134:358\u2013367","journal-title":"Chest"},{"key":"5193_CR26","first-page":"109","volume":"22","author":"S Suliman","year":"2017","unstructured":"Suliman S, Al Harash A, Roberts WN et al (2017) Scleroderma-related interstitial lung disease. Respir Med Case Rep 22:109\u2013112","journal-title":"Respir Med Case Rep"},{"issue":"9","key":"5193_CR27","first-page":"1789","volume":"33","author":"D Launay","year":"2006","unstructured":"Launay D, Remy-Jardin M, Michon-Pasturel U, Mastora I, Hachulla E, Lambert M, Delannoy V, Queyrel V, Duhamel A, Matran R, de Groote P, Hatron PY (2006) High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 33(9):1789\u20131801","journal-title":"J Rheumatol"},{"key":"5193_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.2322031223","volume":"232","author":"SR Desai","year":"2004","unstructured":"Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NSL, Nicholson AG, Colby TV, Denton CP, Black CM, du Bois RM, Wells AU (2004) CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 232:560\u2013567","journal-title":"Radiology"},{"key":"5193_CR29","doi-asserted-by":"publisher","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","volume":"13","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Guti\u00e9rrez-Ocampo et al (2020) Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis Mar 13:101623","journal-title":"Travel Med Infect Dis Mar"},{"issue":"20","key":"5193_CR30","first-page":"30136","volume":"S1201\u20139712","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X et al (2020) Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis S1201\u20139712(20):30136\u201330133","journal-title":"Int J Infect Dis"},{"issue":"10223","key":"5193_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513","journal-title":"Lancet"},{"issue":"4","key":"5193_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Jiang N et al (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20(4):425\u2013434","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"5193_CR33","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M et al (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897\u20131905","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5193_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51(6):1017\u20131026","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5193_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan YH, Lai YN, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J (2020) Coronavirus infections and immune responses. J Med Virol 92(4):424\u2013432","journal-title":"J Med Virol"},{"key":"5193_CR36","doi-asserted-by":"publisher","first-page":"200343","DOI":"10.1148\/radiol.2020200343","volume":"12","author":"X Xie","year":"2020","unstructured":"Xie X, Zhong Z, Zhao W et al (2020) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 12:200343","journal-title":"Radiology"},{"issue":"1","key":"5193_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1148\/radiol.2020200330","volume":"295","author":"P Huang","year":"2020","unstructured":"Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, Hu X, Chen J, Liu B (2020) Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology 295(1):22\u201323","journal-title":"Radiology"},{"key":"5193_CR38","doi-asserted-by":"crossref","unstructured":"Ai T, Yang Z, Hou H, et al (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology;200642","DOI":"10.1148\/radiol.2020200642"},{"key":"5193_CR39","doi-asserted-by":"crossref","unstructured":"Fang Y, Zhang H, Xie J, et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology;200432","DOI":"10.1148\/radiol.2020200432"},{"issue":"5","key":"5193_CR40","first-page":"171","volume":"14","author":"C Faravelli","year":"2019","unstructured":"Faravelli C, Pietrini F, Rotella F et al (2019) Stressful life events at the onset and during the evolution of systemic sclerosis. Int J Clin Rheumatol 14(5):171\u2013178","journal-title":"Int J Clin Rheumatol"},{"issue":"3","key":"5193_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.20389","volume":"51","author":"A Del Rosso","year":"2004","unstructured":"Del Rosso A, Boldrini M, D\u2019Agostino D et al (2004) Health-related quality of life in systemic sclerosis as measured by the short form 36: relationship with clinical and biologic markers. Arthritis Rheum 51(3):475\u2013481","journal-title":"Arthritis Rheum"},{"key":"5193_CR42","doi-asserted-by":"crossref","unstructured":"Matucci Cerinic M, Bruni C, Allanore Y, et al (2020) Systemic sclerosis and the SARS2-COVID-19 virus pandemic: World Scleroderma Foundation preliminary advices for patient management. Ann Rheum Dis. pii: annrheumdis-2020\u2013217407","DOI":"10.1136\/annrheumdis-2020-219533"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05193-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05193-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05193-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:15:08Z","timestamp":1623111308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05193-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5193"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05193-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosures None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}